A start-up named DenovAI, founded by a former EMBL staff scientist, is pioneering a revolutionary approach to expedite and reduce costs in antibody discovery.
AI Utilized to Discover Therapeutic Antibodies miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Israel Innovation Authority predicts Israeli startups will struggle to raise capital, forcing them to shut their operations or move to other countries if uncertainty is not lifted
DenovAI is approved by the Israel Innovation Authority and will receive a $2 million grant from AION Labs and its investment partners Pfizer, AstraZeneca, Merck, Teva and Israel Biotech Fund.
AION Labs, a new innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, has announced a global call for application to identify biomedical scientists and inventors to form a new startup at its headquarters in Rehovot, Israel.